View up-to-date information on BioNTech SE patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20240124609A1 | Application | Human monoclonal antibodies to ganglioside gd2 | A61K2039/505; A61K39/39558; A61K45/06; C07K16/3084; G01N33/57492 | April 18, 2024 |
| EP3920960B1 | Grant | Behandlung mit car-manipulierten t-zellen und zytokinen | A61K2039/5156; A61K2039/5158; A61K2039/55527; A61K2039/55533; A61K2039/572; A61K2239/31; A61K2239/38; A61K35/17; A61K38/20; A61K38/2013; A61K38/2046; A61K39/0011; A61K39/4611; A61K39/4631; A61K39/464402; A61P35/00; C07K14/5418; C07K14/55; C12N2501/2307; C12N2501/2315; C12N2510/00; C12N5/0636 | April 17, 2024 |
| EP4351633A1 | Application | Mittel und verfahren zur aktivierung und zum targeting von immuneffektorzellen | A61K2039/507; A61K2039/53; A61K2039/545; A61K2039/585; A61K2239/26; A61K2239/46; A61K39/4611; A61K39/4631; A61K39/4644; A61K39/464402; A61P35/00; C07K14/7051; C07K16/28; C07K16/30; C07K2317/622; C07K2317/73; C07K2319/02; C07K2319/03; C07K2319/40 | April 17, 2024 |
| WO2024075022A2 | Application | Rna constructs and uses thereof | C07H21/02; C12N15/10; C12N15/11 | April 11, 2024 |
| WO2024074634A1 | Application | Rna compositions targeting claudin-18.2 | A61K2039/505; A61K2039/53; A61K9/0019; A61K9/5146; A61K9/5153; C07K14/505; C07K16/28; C07K2317/10; C07K2317/33; C07K2317/73; C07K2317/732; C07K2317/734; C07K2317/94 | April 11, 2024 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer